Michael David Smith

KALV

Michael David Smith serves as Senior VP, Development at KalVista Pharmaceuticals, Inc. (KALV). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$459.2K

Net Position

Net Seller

$459.2K

Companies Traded

KALV

Active Period

Apr 2021 – Jun 2021

2 total trades

Most Recent

Sell KALV

Jun 3, 2021 · $201.2K

Michael David Smith's Insider Trading at KalVista Pharmaceuticals, Inc. (KALV)

Buys

0 · $0.00

Sells

2 · $459.2K

Total Shares Bought

Total Shares Sold

17,514

KALV Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 3, 2021	Sell	7,500	$26.83	$201.2K	0
Apr 30, 2021	Sell	10,014	$25.76	$258.0K	0

Related Insiders

Benjamin L Palleiko

director, officer: CHIEF EXECUTIVE OFFICER

KALVSell · Mar 10, 2026

Paul K. Audhya

officer: CHIEF MEDICAL OFFICER

KALVSell · Feb 24, 2026

Brian Piekos

officer: Chief Financial Officer

KALVSell · Feb 24, 2026

Nicole Sweeny

officer: Chief Commercial Officer

KALVSell · Feb 24, 2026

Christopher Yea

officer: CHIEF DEVELOPMENT OFFICER

KALVSell · Feb 24, 2026

Venrock Healthcare Capital Partners III, L.P.

KALVBuy · Apr 11, 2025

Explore More Insider Trading Data

KALV Insider Trading Activity

View all insider trades at KalVista Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity